Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Overview
- Classification of HLA Systems
- HLA Typing in Transplantation
- Porter's Five Forces Analysis
- Potential of New Entrants (Moderate)
- Bargaining Power of Suppliers (Low to Moderate)
- Bargaining Power of Buyers (High)
- Threat of Substitute Products (Low)
- Industry Rivalry (High)
- Macroeconomic Factors Analysis
- Healthcare Budget Priorities
- Geopolitical Factors
- Tariffs' Impact on HLA Typing for Transplant Market
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Demand for Solid Organ Transplants
- Growing Prevalence of Blood Cancers
- Market Restraints
- Demand and Supply Gaps in Organ Donations
- High Equipment and Testing Costs
- Market Opportunities
- Growing Focus on Precision Transplantation Procedures
- Expansion of Donor Registries
Chapter 4 Regulatory Landscape
- Regulatory Aspects of HLA Typing for Transplant
- U.S.
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies
- Key Takeaways
- Emerging Technologies
- Next-Generation Sequencing (NGS)-Based HLA Typing
- Eplet Matching Compatibility Analysis
- AI-Driven Bioinformatics
- Long-Read Sequencing Technologies for HLA Typing
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Global HLA Typing for Transplant Market, by Product and Service Type
- Key Takeaways
- Consumables
- Instruments
- Services
- Global HLA Typing for Transplant Market, by Technology
- Key Takeaways
- Molecular Technologies
- Nonmolecular Technologies
- Global HLA Typing for Transplant Market, by Application
- Key Takeaways
- Solid Organ Transplant
- Stem Cell Transplant
- Global HLA Typing for Transplant Market, by End User
- Key Takeaways
- Hospitals and Transplant Centers
- Diagnostic Laboratories
- Research Institutions
- Geographic Breakdown
- Global HLA Typing for Transplant Market, by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 7 Competitive Intelligence
- Key Takeaways
- Company Share Analysis
- Strategic Analysis
List of Tables
Summary Table: Global HLA Typing for Transplant Market, by Region, Through 2030
Table 1: Comparison of HLA Testing Techniques
Table 2: Comparison of HLA Systems
Table 3: Number of Global Solid Organ Transplants, 2024
Table 4: Estimated New Blood Cancer Cases and Deaths in the U.S., 2025
Table 5: Global HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 6: Global HLA Typing for Transplant Market for Consumables, by Region, Through 2030
Table 7: Global HLA Typing for Transplant Market for Instruments, by Region, Through 2030
Table 8: Global HLA Typing for Transplant Market for Services, by Region, Through 2030
Table 9: Global HLA Typing for Transplant Market, by Technology, Through 2030
Table 10: Global HLA Typing for Transplant Market for Molecular Technologies, by Region, Through 2030
Table 11: Global HLA Typing for Transplant Market for Nonmolecular Technologies, by Region, Through 2030
Table 12: Global HLA Typing for Transplant Market, by Application, Through 2030
Table 13: Global HLA Typing for Transplant Market for Solid Organ Transplant, by Region, Through 2030
Table 14: Global HLA Typing for Transplant Market for Stem Cell Transplant, by Region, Through 2030
Table 15: Global HLA Typing for Transplant Market, by End User, Through 2030
Table 16: Global HLA Typing for Transplant Market for Hospitals and Transplant Centers, by Region, Through 2030
Table 17: Global HLA Typing for Transplant Market for Diagnostic Laboratories, by Region, Through 2030
Table 18: Global HLA Typing for Transplant Market for Research Institutions, by Region, Through 2030
Table 19: Global HLA Typing for Transplant Market, by Region, Through 2030
Table 20: North American HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 21: North American HLA Typing for Transplant Market, by Technology, Through 2030
Table 22: North American HLA Typing for Transplant Market, by Application, Through 2030
Table 23: North American HLA Typing for Transplant Market, by End User, Through 2030
Table 24: North American HLA Typing for Transplant Market, by Country, Through 2030
Table 25: European HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 26: European HLA Typing for Transplant Market, by Technology, Through 2030
Table 27: European HLA Typing for Transplant Market, by Application, Through 2030
Table 28: European HLA Typing for Transplant Market, by End User, Through 2030
Table 29: European HLA Typing for Transplant Market, by Country, Through 2030
Table 30: Asia-Pacific HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 31: Asia-Pacific HLA Typing for Transplant Market, by Technology, Through 2030
Table 32: Asia-Pacific HLA Typing for Transplant Market, by Application, Through 2030
Table 33: Asia-Pacific HLA Typing for Transplant Market, by End User, Through 2030
Table 34: Asia-Pacific HLA Typing for Transplant Market, by Country, Through 2030
Table 35: RoW HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 36: RoW HLA Typing for Transplant Market, by Technology, Through 2030
Table 37: RoW HLA Typing for Transplant Market, by Application, Through 2030
Table 38: RoW HLA Typing for Transplant Market, by End User, Through 2030
Table 39: RoW HLA Typing for Transplant Market, by Sub-Region, Through 2030
Table 40: Recent Developments in HLA Typing for Transplant Market, 2023-2025
Table 41: Abbreviations Used in the Global HLA Typing for Transplant Market
Table 42: Information Sources for this Report
Table 43: Agilent Technologies Inc.: Company Snapshot
Table 44: Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 45: Agilent Technologies Inc.: Product Portfolio
Table 46: Agilent Technologies Inc.: News/Key Developments, 2024
Table 47: BD: Company Snapshot
Table 48: BD: Financial Performance, FY 2024 and 2025
Table 49: BD: Product Portfolio
Table 50: BD: News/Key Developments, 2025
Table 51: Bio-Rad Laboratories Inc.: Company Snapshot
Table 52: Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 53: Bio-Rad Laboratories Inc.: Product Portfolio
Table 54: Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 55: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 56: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 57: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 58: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024-2025
Table 59: Illumina Inc.: Company Snapshot
Table 60: Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 61: Illumina Inc.: Product Portfolio
Table 62: Illumina Inc.: News/Key Developments, 2025
Table 63: Oxford Nanopore Technologies plc.: Company Snapshot
Table 64: Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 65: Oxford Nanopore Technologies plc.: Product Portfolio
Table 66: Oxford Nanopore Technologies plc.: News/Key Developments, 2024-2025
Table 67: PacBio: Company Snapshot
Table 68: PacBio: Financial Performance, FY 2023 and 2024
Table 69: PacBio: Product Portfolio
Table 70: PacBio: News/Key Developments, 2025
Table 71: Qiagen: Company Snapshot
Table 72: Qiagen: Financial Performance, FY 2023 and 2024
Table 73: Qiagen: Product Portfolio
Table 74: Qiagen: News/Key Developments, 2025
Table 75: Revvity: Company Snapshot
Table 76: Revvity: Financial Performance, FY 2023 and 2024
Table 77: Revvity: Product Portfolio
Table 78: Thermo Fisher Scientific Inc.: Company Snapshot
Table 79: Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 80: Thermo Fisher Scientific Inc.: Product Portfolio
Table 81: Thermo Fisher Scientific Inc.: News/Key Developments, 2025
Table 82: List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure: Global Market Shares of HLA Typing for Transplant, by Region, 2024
Figure 1: Porter’s Five Forces Analysis of the Global HLA Typing for Transplant Market
Figure 2: Market Dynamics of HLA Typing for Transplant Market
Figure 3: Advantages of NGS-Based HLA Typing
Figure 4: Global Market Shares of HLA Typing for Transplant, by Product and Service Type, 2024
Figure 5: Global Market Shares of HLA Typing for Transplant, by Technology, 2024
Figure 6: Global Market Shares of HLA Typing for Transplant, by Application, 2024
Figure 7: Global Market Shares of HLA Typing for Transplant, by End User, 2024
Figure 8: Global Market Shares of HLA Typing for Transplant, by Region, 2024
Figure 9: North American Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 10: European Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 11: Asia-Pacific Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 12: RoW Market Shares of HLA Typing Market for Transplant, by Sub-region, 2024
Figure 13: Company Shares of Market for HLA Typing for Transplant, 2024
Figure 14: Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 15: Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 16: BD: Revenue Shares, by Business Unit, FY 2025
Figure 17: BD: Revenue Shares, by Country/Region, FY 2025
Figure 18: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 19: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 20: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 21: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 22: Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 23: Oxford Nanopore Technologies plc.: Revenue Share, by Country/Region, FY 2024
Figure 24: PacBio: Revenue Share, by Country/Region, FY 2024
Figure 25: Qiagen: Revenue Share, by Business Unit, FY 2024
Figure 26: Qiagen: Revenue Share, by Country/Region, FY 2024
Figure 27: Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 28: Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 29: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 30: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024